Related Experiment Video

Updated: Aug 19, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
07:32

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography

Published on: March 30, 2022

Matrix metalloproteinases target protease-activated receptors on the tumor cell surface

Duanqing Pei1

  • 1Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455, USA. pei_duanqing@gibh.ac.cn

Cancer Cell
|March 16, 2005
PubMed

Insights

Matrix metalloproteinases (MMPs) activate protease-activated receptors (PARs) on tumor cells, promoting cancer invasion and metastasis. This novel MMP-PAR signaling pathway may drive tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Matrix metalloproteinases (MMPs) degrade the extracellular matrix (ECM), facilitating tumor invasion and metastasis.
  • MMPs also cleave non-ECM substrates, suggesting broader roles in cancer progression.
  • Protease-activated receptors (PARs) are emerging as novel targets for MMPs.

Purpose of the Study:

  • To investigate the role of MMPs in activating PARs on tumor cells.
  • To elucidate the signaling pathway initiated by MMP-mediated PAR activation.
  • To identify novel therapeutic targets for inhibiting tumor cell migration and invasion.

Main Methods:

  • Utilized biochemical assays to detect MMP activity.
  • Employed cell-based assays to measure tumor cell migration and invasion.
  • Investigated intracellular signaling pathways activated by PAR1.
  • Analyzed the expression and localization of MMPs and PAR1 in tumor tissues.

Main Results:

  • Stromal-derived MMP1 was found to cleave and activate the thrombin receptor PAR1 on the tumor cell surface.
  • PAR1 activation by MMP1 triggered intracellular G protein signaling.
  • This signaling cascade initiated a program of tumor cell migration and invasion.
  • Demonstrated a novel MMP-PAR signaling axis in tumor progression.

Conclusions:

  • The MMP-PAR axis represents a newly identified signaling pathway crucial for tumor progression.
  • MMP-mediated PAR1 activation promotes tumor cell invasiveness.
  • This pathway offers a potential therapeutic target for anti-cancer strategies.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...